Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
3(25%)
Results Posted
25%(1 trials)
Terminated
1(8%)

Phase Distribution

Ph phase_1
5
42%
Ph early_phase_1
1
8%
Ph not_applicable
1
8%

Phase Distribution

6

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution7 total trials
Early Phase 1First-in-human
1(14.3%)
Phase 1Safety & dosage
5(71.4%)
N/ANon-phased studies
1(14.3%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

57.1%

4 of 7 finished

Non-Completion Rate

42.9%

3 ended early

Currently Active

3

trials recruiting

Total Trials

12

all time

Status Distribution
Active(4)
Completed(4)
Terminated(3)
Other(1)

Detailed Status

Completed4
Recruiting2
Withdrawn2
Terminated1
Not yet recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
3
Success Rate
80.0%
Most Advanced
Phase 1

Trials by Phase

Early Phase 11 (14.3%)
Phase 15 (71.4%)
N/A1 (14.3%)

Trials by Status

completed433%
terminated18%
not_yet_recruiting18%
recruiting217%
active_not_recruiting18%
unknown18%
withdrawn217%

Recent Activity

3 active trials
Showing 5 of 12
withdrawnphase_1

PET Imaging Using 64Cu-Tz-SarAr and hu5B1-TCO in People With Pancreatic, Colorectal, Bladder Cancer or Cancers With Elevated CA19.9

NCT05737615
recruitingearly_phase_1

Melatonin as a Neuroprotective Therapy in Neonates With HIE Undergoing Hypothermia

NCT02621944
active_not_recruitingphase_1

A Study of Melphalan in People With Lymphoma Getting an Autologous Hematopoietic Cell Transplant

NCT05540340
recruiting

Population Pharmacokinetics of Anti-infectives in Critically Ill Children

NCT02539407
not_yet_recruitingphase_1

Development of a Bayesian Estimator for Calculating Plasma Iohexol Clearance

NCT05136963
View all 12 trials

Clinical Trials (12)

Showing 12 of 12 trials
NCT05737615Phase 1

PET Imaging Using 64Cu-Tz-SarAr and hu5B1-TCO in People With Pancreatic, Colorectal, Bladder Cancer or Cancers With Elevated CA19.9

Withdrawn
NCT02621944Early Phase 1

Melatonin as a Neuroprotective Therapy in Neonates With HIE Undergoing Hypothermia

Recruiting
NCT05540340Phase 1

A Study of Melphalan in People With Lymphoma Getting an Autologous Hematopoietic Cell Transplant

Active Not Recruiting
NCT02539407

Population Pharmacokinetics of Anti-infectives in Critically Ill Children

Recruiting
NCT05136963Phase 1

Development of a Bayesian Estimator for Calculating Plasma Iohexol Clearance

Not Yet Recruiting
NCT01251601

The Effect of Pregnancy on the PK of Isentress®: A Longitudinal Investigation in the Second and Third Trimesters

Withdrawn
NCT03248349

Population Pharmacokinetics of Antibiotics in Critically Ill Children (POPSICLE)

Unknown
NCT02548780Not Applicable

LifePearl-Doxo Pharmacokinetic (PK) Study

Completed
NCT01855061

Biomarker Development for Response Prediction by DNA Mutational Analysis

Terminated
NCT00989586Phase 1

Veltuzumab and Milatuzumab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Completed
NCT02169141

Pharmacokinetics of Levofloxacin and Capreomycin in Multidrug-Resistant Tuberculosis Patients

Completed
NCT00861458Phase 1

Bioavailability Study Of PF-00868554 Administered As 3x250mg Oral Tablets (Wet Granulate, 3x250mg Oral Tablets (Dry Granulate) And 750mg Solution Under Fed State

Completed

All 12 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
12